Center for Environmentally Beneficial Catalysis
  • Home
  • Meet our two newest industry partners

Meet our two newest industry partners

Tuesday, May 2, 2017

CEBC welcomes W. R. Grace and Chemours as industry partners.  To date, the center has been privileged to work with a total of 25 industry partners, including our 9 currently active partners.

W. R. Grace is a leading global supplier of catalysts and engineered materials, built on talent, technology and trust. The company’s two industry-leading business segments — Catalysts and Materials — provide innovative products, technologies and services that enhance products and processes worldwide. Grace employs approximately 3,700 people in more than 30 countries.

Chemours Titanium Technologies in 1931 pioneered the chemistry on which their Ti-Pure™ formulations are based. The company continues as the global leader in TiO2 production today. Chemours titanium dioxide is a key component of some of the whitest, brightest, and most efficient applications — brilliant paints, pristine plastic, gleaming laminates, and durable automotive and aerospace coatings.



CEBC Calendar

March 4, Thursday - Industry Colloquium 
9:00 a.m., via Zoom
Allyn Kaufmann, US Whitespace & Innovation Lead
GlaxoSmithKline
"Serial Innovation in Consumer Heathcare - Intersection of Chemistry and the Consumer"

March 10, Wednesday - Mandatory Safety Meeting 
9:00 a.m., via Zoom
Mandatory for all CEBC researchers working at 1501 Wakarusa

March 25, Thursday - Industry Colloquium 
9:00 a.m., via Zoom
Nikola Juhasz, Global Technical Director, Sustainability
Sun Chemical Corporation, Carlstadt, NJ
"Sustainability of Packaging Industry"

April 1, Thursday - Industry Colloquium 
9:00 a.m., via Zoom
Sagar Sarsani, Project Leader
Sabic, Sugarland, TX
"Chemical Industry R&D Career Pathways"

April 12 & 13, Monday & Tuesday - Spring Advisory Boards Meeting
& Project Evaluations
 

1:00-3:00 p.m. each day, via Zoom
Click here to register

KU Today
48 nationally ranked graduate programs.
—U.S. News & World Report
Pharmacy school No. 2 nationally for NIH funding